Smart Money Alert
Suven Life Sciences Limited
IncreasedSAST
SUVENHealthcare Research, Analytics & TechnologyMarket Cap₹9K Cr
Value
₹438 Cr
Shares
3,17,68,764
Price
₹137.74
Stake
65.40% → 69.57%
JA
Jasti Property and Equity Holdings Private Limited
Promoter
The move
Jasti Property and Equity Holdings Private Limited increased its stake in Suven Life Sciences from 65.40% to 69.57% by acquiring 3,17,68,764 shares for ₹437.58 Cr at ₹137.74 apiece through a preferential allotment.
About Suven Life Sciences Limited
Visit stock A clinical-stage biopharmaceutical company engaged in the acquisition, development, and commercialization of novel therapeutics for treating neurodegenerative disorders. Suven Life Sciences operates across research, analytics, and technology platforms to advance its pipeline of investigational drugs targeting diseases affecting the nervous system. The company focuses on bringing innovative treatment solutions to patients suffering from neurological conditions through rigorous clinical development processes.
Get the next move the moment it happens.
Follow the investors and Suven Life Sciences Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Quant Mutual FundExited
Quant Mutual Fund has dropped from Suven Life Sciences Limited's disclosed shareholder list after previously holding 1.78 percent, indicating either a complete exit or a reduction of its stake to below the 1 percent reporting requirement.
19 Jul 2026
Read more Abakkus Mutual FundDecreased
Abakkus Mutual Fund decreased its stake in Suven Life Sciences from 1.13% to 1.00%, selling 168,636 shares. The value of the sold shares is approximately ₹5.49 Cr, calculated at the last closing price of ₹325.90 apiece.
16 Jul 2026
Read more